MOLN

MOLECULAR PARTNERS AG MOLN

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 5 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$0

Quarter to Dec 31

Net income

$-61.65M

Quarter to Dec 31

Free cash flow

$-51.97M

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$13.81M total
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

MOLN key financials by period

Reported revenue, net income and operating margin by fiscal year, from MOLECULAR PARTNERS AG's annual filings on SEC EDGAR.

MOLECULAR PARTNERS AG reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2024$5.0M$-54.0M—
FY 2023$7.0M$-62.0M—
FY 2022$189.6M$117.9M61.5%
FY 2021$9.8M$-63.8M—
FY 2020$9.3M$-62.8M—
FY 2019$20.4M$-36.3M-179.9%
Source: MOLN filings on SEC EDGAR →

About MOLECULAR PARTNERS AG (MOLN): stock profile, AI score and financials

MOLECULAR PARTNERS AG (MOLN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MOLN is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 5 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), MOLECULAR PARTNERS AG reports net income of $-61.7M, free cash flow of $-52.0M. Top institutional holders of MOLN by reported 13-F value include SUVRETTA CAPITAL MANAGEMENT, BVF, CITADEL ADVISORS, based on the most recent SEC filings. MOLN trades on the Nasdaq exchange and files with the SEC under CIK 1745114. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MOLN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MOLECULAR PARTNERS AG directly from SEC EDGAR.

SEC EDGAR: CIK 1745114 →